Clinical Laboratory Tests Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), By End-use, And Segment Forecasts, 2018 - 2024

Industry Insights

The global clinical laboratory tests market size was valued at USD 107.7 billion in 2015. Rising population of health-conscious people coupled with an increase in chronic and metabolic disorders is one of the key factors affirming growth.

The growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to serve as a high impact rendering driver over the forecast period. Cardiovascular disease is one of the fatal disorders and the leading cause of death across the globe. Rising frequency of detrimental habits like consumption of unhealthy food, insufficient exercise, and rising obesity are responsible for the increase in incidence of chronic diseases

U.S. clinical laboratory tests market, by type, 2013 - 2024 (USD Billion)

The growing geriatric population base, primarily in the European and North American countries, is also anticipated to provide huge growth opportunities in this area. The increase in aging population and amplified acute and long-term healthcare needs are driving the growth of clinical laboratory tests market at a global level. Moreover, rising awareness amongst people and healthcare professionals about the need of regular body profiling is also estimated to enhance usage of clinical tests.

Increasing adoption of laboratory automation systems is anticipated to accentuate growth of this market over the next decade. For example, approximately more than 30% of the laboratories in North America, Europe, and Japan have implemented a significant degree of laboratory automation.

Advantages of automation such as its ability to reduce errors, improve efficacy, and enhance patient safety by integrating electronic, mechanical, and informatics tools are expected to propel the market.

Type Insights

The most commonly performed clinical laboratory tests are Complete Blood Count (CBC), Basic Metabolic Panel (BMP), comprehensive metabolic panel, lipid panel, and HbA1c tests. Blood tests such as CBC have been suggested by healthcare professionals as the first line of diagnostic tests for various infectious and metabolic diseases since long.

BMP dominated the overall market in terms of revenue of around 13.0% in 2015, owing to the increasing demand for preventive medicine and growing prevalence of lifestyle-induced diseases, such as obesity and metabolic abnormalities. BMP consists of a set of tests that provide information to the medical examiner regarding problems caused by chemical imbalance in the body.

However, lipid panel consisting of screening tests for cholesterol and triglyceride levels is anticipated to witness lucrative growth over the forecast period. Cardiovascular disorders and diabetes demand for testing of lipid levels at specific time intervals, which is further estimated to provide this segment with increasing acceptance due to rise in prevalence of these disorders.

End-use Insights

Clinical laboratory tests are extensively used in central laboratories and in primary clinics, such as physicians’ clinics and other standalone laboratories. Introduction of portable and rapid analyzers is a key technology advancement fueling growth of end-use segments

Global liver panel market, by type, 2015 (USD Billion)

Central laboratories dominated the end-use segment with a share of over 40.0% in 2015. However, primary clinics segment is estimated to grow at the fastest rate over the forecast period with a significant CAGR. Rising awareness of physicians about in-clinic testing and increasing demand for rapid results are the major factors contributing to growth.

Regional Insights

North America was the largest regional market in 2015. High penetration of technologically advanced products, lab automation rates, high target disease prevalence, and growing patient awareness in the region are some of the factors that can be attributed to its large share.

The presence of a favorable reimbursement framework (especially post the implementation of the Affordable Care Act) and sophisticated healthcare infrastructure is also expected to drive regional market growth over the next 8 years.

Asia Pacific is expected to gain revenue share over the forecast period. Improving healthcare infrastructure supporting the implementation of advanced diagnostic technologies in the emerging economies of India and China is one of the factors expected to drive regional growth during the forecast period.

Competitive Insights

The clinical laboratory tests market is consolidated in nature and is, therefore, marked by an extensive presence of mergers and acquisitions. Some of the key players are Quest Diagnostics; Merck KgaA; Laboratory Corporation of America Holdings.; Genoptix; Healthscope; Labco; Charles River Laboratories, OPKO Health, Inc.; and Abbott.

Key players such as Laboratory Corporation of America Holdings, Sonic Healthcare Ltd., and Quest diagnostics are identified as independent laboratories that have an extensive market presence and are expected to collectively hold major share in the coming decade.

Report Scope 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the clinical laboratory testing market on the basis of type, end-use, and region:

• Type Outlook (Revenue, USD Billion, 2013 - 2024)

  • Complete Blood Count

  • HGB/HCT Testing

  • Basic Metabolic Panel Testing

  • BUN Creatinine Testing

  • Electrolytes Testing

  • HbA1c Testing

  • Comprehensive Metabolic Panel Testing

  • Liver PanelTesting

    • Hepatitis

    • Bile Duct Obstruction

    • Liver Cirrhosis

    • Liver Cancer

    • Bone disease

    • Autoimmune Disorders

    • Others

  • Renal Panel Testing

  • Lipid Panel Testing

• End-use Outlook (Revenue, USD Billion, 2013 - 2024)

  • Central Laboratories

  • Primary Clinics

• Regional Outlook (Revenue, USD Billion, 2013 - 2024)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa